FDA approves DEFINITY (Perflutren Lipid Microsphere) for pediatric echocardiogram enhancement.

Lantheus Holdings announces FDA approval of DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for pediatric patients with suboptimal echocardiograms. The approval extends the benefits of the product to healthcare professionals working with young individuals, and DEFINITY is the most utilized, extensively studied, and trusted diagnostic ultrasound enhancing agent in the US.

March 04, 2024
4 Articles

Further Reading